An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result

Prenatal Diagnosis

Volumn 29, Issue 5, 2008, Pages 514-519

  Kobelka, Christine ^a,b   Mattman, Andre ^a   Langlois, Sylvie ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Down syndrome; Genetic counselling; Maternal serum screen; Prenatal; Psychosocial

Indexed keywords

ADULT; AMNIOCENTESIS; ANXIETY; ARTICLE; DECISION MAKING; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; GENETIC COUNSELING; HUMAN; MATERNAL ATTITUDE; MATERNAL SERUM; PREGNANCY TERMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RELIGION; RISK FACTOR; SCREENING;

ABORTION, SPONTANEOUS; ADULT; AMNIOCENTESIS; ANXIETY; DECISION MAKING; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HEMATOLOGIC TESTS; HUMANS; MOTHERS; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 66849095957     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2235     Document Type: Article

References (30)

1. Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A. 1991. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn 11: 381-385.
2. Al-Jader LN, Parry-Langdon N, Smith RJ. 2000. Survey of attitudes of pregnant women towards Down syndrome screening. Prenat Diagn 20: 23-29.
3. Carroll JC, Brown JB, Reid AJ, Pugh P. 2000. Women's experience of maternal serum screening. Can Fam Physician 46: 614-620.
4. Caughey AB, Washington AE, Gildengorin V, Kuppermann M. 2004. Assessment of demand for prenatal diagnostic testing using willingness to pay. Obstet Gynecol 103: 539-545.
5. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. 1993. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 81: 72-77.
6. Chiang HH, Chao YM, Yuh YS. 2006. Informed choice of pregnant women in prenatal screening tests for Down's syndrome. J Med Ethics 32: 273 -277.
7. Chilaka VN, Konje JC, Stewart CR, Narayan H, Taylor DJ. 2001. Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn 21: 159-164.
8. Freda MC, DeVore N, Valentine-Adams N, Bombard A, Merkatz IR. 1998. Informed consent for maternal serum alpha-fetoprotein screening in an inner city population: how informed is it? JObstet Gynecol Neonatal Nurs 27: 99-106.
9. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. 1999. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn 19: 1-7.
10. Haddow JE, Palomaki GE, Knight GJ, et al 1992 Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl JMed327: 588-593.
11. Julian-Reynier C, Macquart-Moulin G, Moatti JP, Aurran Y, Cha- bal F, Ayme S. 1994. Reasons for women's non-uptake of amnio- centesis. Prenat Diagn 14: 859-864.
12. Lumley MA, Zamerowski ST, Jackson L, Dukes K, Sullivan L. 2006. Psychosocial correlates of pregnant women's attitudes toward prenatal maternal serum screening and invasive diagnostic testing: beyond traditional risk status. Genet Test 10: 131-138.
13. Marteau TM, Cook R, Kidd J, et al. 1992. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 12: 205-214.
14. Marteau TM, Kidd J, Michie S, Cook R, Johnston M, Shaw RW. 1993. Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial. J Psychosom Obstet Gynaecol 14: 185-196.
15. Michie S, Dormandy E, Marteau TM. 2003. Informed choice: understanding knowledge in the context ofscreening uptake. Patient Educ Couns 50: 247- 253.
16. Michie S, Smith D, Marteau TM. 1999. Prenatal tests: how are women deciding? Prenat Diagn 19: 743-748.
17. Mueller VM, Huang T, Summers AM, Winsor SH. 2005. The influence of risk estimates obtained from maternal serum screening on amniocentesis rates. Prenat Diagn 25: 1253-1257.
18. Roelofsen EE, Kamerbeek LI, Tymstra TJ, Beekhuis JR, Mant- ingh A. 1993. Women's opinions on the offer and use of maternal serum screening. Prenat Diagn 13: 741-747.
19. Rowe HJ, Fisher JR, Quinlivan JA. 2006. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice. Aust N Z J Obstet Gynaecol 46: 433-439.
20. Santalahti P, Aro AR, Hemminki E, Helenius H, Ryynanen M. 1998a. On what grounds do women participate in prenatal screening? Prenat Diagn 18: 153-165.
21. Santalahti P, Hemminki E, Latikka AM, Ryynanen M. 1998b. Women's decision-making in prenatal screening. Soc Sci Med 46: 1067-1076.
22. Santalahti P, Latikka AM, Ryynanen M, Hemminki E. 1996 Women's experiences of prenatal serum screening. Birth 23: 101-107.
23. Smith DK, Shaw RW, Marteau TM. 1994. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ 309: 776.
24. Statham H, Green J. 1993. Serum screening for Down's syndrome: some women's experiences. BMJ 307: 174-176.
25. Suriadi C, Jovanovska M, Quinlivan JA. 2004. Factors affecting mothers' knowledge of genetic screening. Aust N Z J Obstet Gynaecol 44: 30-34.
26. Tercyak KP, Johnson SB, Roberts SF, Cruz AC. 2001. Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns 43: 73 -84.
27. van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G. 2005. Are pregnant women making informed choices about prenatal screening? Genet Med 7: 332-338.
28. van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G. 2006. Informed decision making in the context of prenatal screening. Patient Educ Couns 63: 110-117.
29. Vergani P, Locatelli A, Biffi A, et al. 2002. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older. Prenat Diagn 22: 769-774.
30. Weinans MJ, Huijssoon AM, Tymstra T, Gerrits MC, Beekhuis JR, Mantingh A. 2000. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn 20: 705-708.